Related Experiment Video
Updated: Jul 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Pneumonia above 80 years, admitted to the hospital]
G Zubillaga Garmendia1, E Sánchez Haya, J Benavente Claveras
1Servicios de Medicina Interna, Hospital Donostia, Servicio Vasco de Salud, Departamento de Medicina, Universidad del País Vasco (UPV-EHU), Spain. g.zubillaga@terra.es
Objective:
To analyze and compare differences in patients older than 80 years with Community acquired Pneumonia admitted in Internal Medicine or Pneumology of a General Hospital from the Emergency Room.
Material And Methods:
Retrospective study of all the 277 patients above 80 years admitted into the Hospital in 2005 with the main diagnosis of Pneumonia.
Results:
84% community-acquired, 16% from Institutions. Mean age: 85.8 y (48% men, 52% women). 19% FINE-3, 49% FINE-4, 32% FINE-5. Known etiology: 25% (Pneumococcal 19%, H. Influenzae and other Gram (-) 6%. 75% treated by Internists, 22% treated by Pneumologists. Standard Guidelines followed up by 30,5% a variant 60% (Equal by Internists or Pneumologists). Time door-1st antibiotic dose 6.6 hours. Global Mortality 16.7%. Women died at 87.4 y, men at 84.5 y (p = 0.035). Mortality FINE 3-4-5: 4.5, 12.4, 30% respectively. Mortality treated before 4 hours: 34.6%, after 4 hours: 11.5% (p = 0.01). Many more FINE 5 cases in Int. Medicine than Pneumology. Mortality by Internists 22%. Mortality by Pneumologists 3% (p = 0.001). Mortality similar following strict guidelines or variant.
Conclusions:
a) Internist receive patients sicker than Pneumologists; b) Important mortality in these very old patients of 16.7%, and progressive according the FINE severity index, in spite of correct therapy; c) Rapid initiation of Antibiotics did not decreased mortality; d) Mortality did not change following strict or variant Guidelines; and e) There are areas of quality improvement in our Hospitals.
Insights
Elderly patients over 80 with community-acquired pneumonia admitted to Internal Medicine had higher mortality than those admitted to Pneumology, indicating a need for improved care strategies for sicker patients.
Area of Science:
- Geriatric Medicine
- Infectious Diseases
- Hospital Medicine
Context:
- Community-acquired pneumonia (CAP) poses a significant threat to elderly individuals.
- Optimal management strategies for CAP in patients over 80 remain an area of active research.
- Understanding disparities in care between Internal Medicine and Pneumology departments is crucial for improving outcomes.
Purpose:
- To compare clinical characteristics and outcomes of patients aged 80 and above with CAP admitted to Internal Medicine versus Pneumology services.
- To identify factors influencing mortality in this vulnerable patient population.
Summary:
- A retrospective study of 277 patients over 80 with CAP found that those treated by Internal Medicine departments were often sicker and had higher mortality rates (22%) compared to those treated by Pneumology (3%).
- Despite similar adherence to guidelines and treatment initiation times, severity (FINE score) and patient disposition significantly impacted outcomes.
- Overall mortality was 16.7%, increasing with disease severity, and rapid antibiotic administration did not significantly reduce mortality.
Impact:
- Internal Medicine departments receive a disproportionate number of severely ill elderly CAP patients.
- There is a critical need for enhanced quality improvement initiatives in managing CAP in the very old.
- Findings highlight potential areas for optimizing inter-departmental collaboration and patient stratification for better CAP management in geriatric populations.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia II: Pathophysiology

